There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine candidate developed by the International AIDS Vaccine Initiative (IAVI).

WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ongoing outbreak in Uganda’s capital city.